in Newswire Published on September 27, 2023

Class Action Alleges Similasan Eye Drops Illegally Sold as Homeopathic Drugs Without FDA Approval

Plowden v. Similasan Corp.

Filed: September 26, 2023 § 1:23-cv-02511

A proposed class action alleges Similasan has illegally marketed its eye drops as homeopathic drugs capable of curing a range of ophthalmic conditions.

Case Spotlight

Hair Relaxer Lawsuits Newsletter

Stay Current

Sign Up For
Our Newsletter

New cases and investigations, settlement deadlines, and news straight to your inbox.

This browser does not support PDFs. Please download the PDF to view it: Download PDF.

Last Updated on September 27, 2023 — 4:51 PM

Corrado Rizzi

Corrado Rizzi is the Senior Managing Editor of

About is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.